What is the pH Level of Reconstituted Innotox 100u Solution?
The pH of the reconstituted Innotox 100 U solution lands in the 6.0–7.0 range at room temperature (≈25 °C). Most batches hover around 6.2–6.8, which is close to neutral but slightly acidic because of the phosphate‑based buffer that keeps the toxin stable in liquid form. This range is what you’ll normally see on a calibrated pH meter after the 0.9 % saline diluent is added to the 100 U vial.
In practice, the exact pH you measure can shift by a few tenths depending on the temperature of the diluent, the lot‑to‑lot variation of the buffer, and how long the solution sits before you use it. For the latest lot‑specific pH data, you can check the official product page of innotox 100u.
What Is Innotox 100 U?
Innotox is a sterile, apyrogenic, liquid formulation of botulinum toxin type A (900 kDa) produced by LG Life Sciences. It is supplied as a 100‑unit vial together with a separate diluent (0.9 % sodium chloride for injection). Because the toxin is already in solution, the product does not require the freeze‑drying step that many other botulinum toxin products need. The formulation is designed to be ready‑to‑use after simple reconstitution and to maintain potency for up to 24 h when stored under recommended conditions.
How the Solution Is Prepared
Reconstituting Innotox is straightforward, but the method you use directly influences the final pH. Follow the steps below to achieve the target pH range while preserving toxin activity.
- Allow the diluent to reach room temperature (≈20–25 °C). Cold saline can lower the pH slightly after mixing.
- Using a syringe, withdraw 2 mL of 0.9 % NaCl (the standard diluent volume for 100 U). The pH of the diluent itself is typically 5.5–6.5.
- Slowly inject the saline into the Innotox vial. Swirl gently for about 30 seconds; avoid vigorous shaking to prevent protein denaturation.
- Let the mixture stand for 1–2 minutes. This pause allows the buffer system to equilibrate.
- Measure the pH with a calibrated meter (see the “Measuring pH” section for details).
If you skip the temperature‑equilibration step or use a diluent that’s far outside the typical pH window, you may see the final pH drift toward the extremes of the 5.8–7.2 range.
Measuring pH Accurately
Because even a small pH shift can affect patient comfort, a calibrated pH meter is the recommended tool. Here’s a quick checklist to ensure reliable readings:
- Calibrate the meter with at least two buffer standards (pH 4.0 and pH 7.0) before each use.
- Allow the reconstituted solution to reach 25 °C (or the temperature at which you intend to store it) before recording the value.
- Immerse the electrode tip fully, swirl gently, and wait for the reading to stabilize (usually 30–60 seconds).
- Record the result to the nearest 0.05 pH unit for documentation.
If a pH meter isn’t available, pH indicator strips can give a ballpark figure (≈±0.2 units), but they are not suitable for precise lot‑release testing.
Why the pH Falls in This Range
Innotox uses a phosphate buffer system (≈10 mM KH₂PO₄/K₂HPO₄) to maintain a slightly acidic pH while protecting the toxin’s tertiary structure. The buffer capacity is intentionally modest so that the solution can accommodate minor pH fluctuations without compromising stability.
Key contributors to the final pH include:
- Diluent pH: Most commercially available 0.9 % NaCl solutions have a pH of 5.5–6.5 due to dissolved CO₂.
- Buffer concentration: Higher buffer strength pushes the pH toward the buffer’s pKa (≈6.86 for phosphate at 25 °C).
- Temperature: The pKa of phosphate shifts with temperature (≈–0.0028 pH / °C), meaning a colder solution can be slightly more acidic.
- Storage time: Over the 24‑hour post‑reconstitution window, CO₂ from the air can dissolve slightly, nudging the pH down by ~0.05–0.10 units.
Clinical Relevance of the pH
A pH in the 6.2–6.8 range is generally well tolerated when injected intradermally or intramuscularly. However, if the pH drops below 6.0, some patients may notice a brief stinging sensation because the acidity can trigger transient activation of nociceptors. Conversely, a pH above 7.0 can reduce the solubility of the toxin complex, potentially leading to a slower onset of action.
In clinical practice, a slight variation within the 6.0–7.0 window does not affect the overall potency of the product, as the toxin’s active